Literature DB >> 10417134

Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.

S M Burns1, S I Hull.   

Abstract

To determine the importance of the O75 O antigen and the K5 capsular antigen in resistance to phagocytosis and phagocytic killing, we used previously described O75(-) and K5(-) mutants from an O75(+) K5(+) wild-type uropathogenic Escherichia coli strain in phagocytosis assays with polymorphonuclear leukocytes (PMNs) and monocytes. At a 10-to-1 ratio of bacteria to phagocytes and in the presence of 10% serum, the parental strain GR-12 was resistant to both PMNs and monocytes over a 2-h incubation period. The O75(-) and K5(-) mutants were similar in sensitivity to killing by both PMNs and monocytes, decreasing in viability by 80% in the first hour. Yet, a significant difference in killing between the O75(-) and K5(-) mutants was observed in the first 15 min of incubation. The K5(-) mutant decreased in numbers by almost 60%, while the O75(-) mutant increased in numbers similarly to GR-12 in the first 15 min. The difference in killing was found not to be due to the rate of opsonization. To further determine the mechanism of resistance, a fluorescence assay was used to differentiate attached and internalized bacteria. The K5 capsule hindered the association of both the wild-type strain and the O75(-) mutant in the initial incubation time with PMNs. In conclusion, both the K5 capsule and O75 O antigen play crucial roles in resistance to phagocytosis over time.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417134      PMCID: PMC96650     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

Review 1.  The biologic significance of bacterial encapsulation.

Authors:  A S Cross
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 2.  The role of bacterial polysaccharide capsules as virulence factors.

Authors:  E R Moxon; J S Kroll
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism.

Authors:  U Grunwald; X Fan; R S Jack; G Workalemahu; A Kallies; F Stelter; C Schütt
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

4.  Phagocytosis: an overview.

Authors:  C J van Oss
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.

Authors:  P M Allen; I Roberts; G J Boulnois; J R Saunders; C A Hart
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

6.  Measurement of nonopsonic phagocytic killing by human and mouse phagocytes.

Authors:  R F Rest; D P Speert
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.

Authors:  C Vermeulen; A Cross; W R Byrne; W Zollinger
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Authors:  R C Arduino; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 9.  Escherichia coli serotyping and disease in man and animals.

Authors:  F Orskov; I Orskov
Journal:  Can J Microbiol       Date:  1992-07       Impact factor: 2.419

10.  Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.

Authors:  T Iwahi; A Imada
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

View more
  16 in total

1.  Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages.

Authors:  Melha Mellata; Maryvonne Dho-Moulin; Charles M Dozois; Roy Curtiss; Brigitte Lehoux; John M Fairbrother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay.

Authors:  James R Johnson; Timothy T O'Bryan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Promoter orientation of the immunomodulatory Bacteroides fragilis capsular polysaccharide A (PSA) is off in individuals with inflammatory bowel disease (IBD).

Authors:  Lucy E Blandford; Emma L Johnston; Jeremy D Sanderson; William G Wade; Alistair J Lax
Journal:  Gut Microbes       Date:  2019-02-07

4.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

5.  Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

Authors:  T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-03       Impact factor: 3.267

Review 6.  Virulence and Fitness Determinants of Uropathogenic Escherichia coli.

Authors:  Sargurunathan Subashchandrabose; Harry L T Mobley
Journal:  Microbiol Spectr       Date:  2015-08

7.  Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.

Authors:  Varinder Kumar; N k Ganguly; Kusum Joshi; Rahul Mittal; Kusum Harjai; Sanjay Chhibber; Saroj Sharma
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

8.  Extraintestinal pathogenic Escherichia coli survives within neutrophils.

Authors:  Helen Nazareth; Stacy A Genagon; Thomas A Russo
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

9.  The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.

Authors:  György Schneider; Ulrich Dobrindt; Holger Brüggemann; Gábor Nagy; Britta Janke; Gabriele Blum-Oehler; Carmen Buchrieser; Gerhard Gottschalk; Levente Emödy; Jörg Hacker
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.

Authors:  Darren Abbanat; Todd A Davies; Karen Amsler; Wenping He; Kellen Fae; Sarah Janssen; Jan T Poolman; Germie P J M van den Dobbelsteen
Journal:  Clin Vaccine Immunol       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.